APA

Amin E. M., Oltean S., Hua J., Gammons M. V. R., Hamdollah-Zadeh M., Welsh G. I., Cheung M., Ni L., Kase S., Rennel E. S., Symonds K. E., Nowak D. G., Royer-Pokora B., Saleem M. A., Hagiwara M., Schumacher V. A., Harper S. J., Hinton D. R., Bates D. O. & Ladomery M. R. (20120206). WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. : Cancer cell.

Chicago

Amin Elianna M, Oltean Sebastian, Hua Jing, Gammons Melissa V R, Hamdollah-Zadeh Maryam, Welsh Gavin I, Cheung Man-Kim, Ni Lan, Kase Satoru, Rennel Emma S, Symonds Kirsty E, Nowak Dawid G, Royer-Pokora Brigitte, Saleem Moin A, Hagiwara Masatoshi, Schumacher Valérie A, Harper Steven J, Hinton David R, Bates David O and Ladomery Michael R. 20120206. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. : Cancer cell.

Harvard

Amin E. M., Oltean S., Hua J., Gammons M. V. R., Hamdollah-Zadeh M., Welsh G. I., Cheung M., Ni L., Kase S., Rennel E. S., Symonds K. E., Nowak D. G., Royer-Pokora B., Saleem M. A., Hagiwara M., Schumacher V. A., Harper S. J., Hinton D. R., Bates D. O. and Ladomery M. R. (20120206). WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. : Cancer cell.

MLA

Amin Elianna M, Oltean Sebastian, Hua Jing, Gammons Melissa V R, Hamdollah-Zadeh Maryam, Welsh Gavin I, Cheung Man-Kim, Ni Lan, Kase Satoru, Rennel Emma S, Symonds Kirsty E, Nowak Dawid G, Royer-Pokora Brigitte, Saleem Moin A, Hagiwara Masatoshi, Schumacher Valérie A, Harper Steven J, Hinton David R, Bates David O and Ladomery Michael R. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. : Cancer cell. 20120206.